An atypical recurrence of endometrial carcinoma following estrogen replacement therapy

被引:4
作者
Carr, JA
Schoon, PA
Look, KY
机构
[1] Dept. of Obstetrics and Gynecology, Section Gynecologic Oncology, Indiana Univ. School of Medicine, Indianapolis
关键词
D O I
10.1006/gyno.1996.0082
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Following an abdominal hysterectomy and bilateral salpingoophorectomy wherein a superficial (1.6 mm) well-differentiated endometrial cancer and bilateral ovarian serous cystadenomas were discovered, estrogen replacement was given, One year later the patient presented with a 9 x 7-cm left groin recurrence. Patients with endometrial carcinoma may request estrogen replacement. The benefits of such replacement are well recognized; however, these patients also need to be counselled that hormonal replacement may be complicated by recurrence. Physicians need to be cognizant of symptoms or signs which would suggest disease recurrence at unusual sites in these patients who are perceived as being at low risk for recurrent disease. (C) 1996 Academic Press, Inc.
引用
收藏
页码:498 / 499
页数:2
相关论文
共 14 条
  • [1] ENDOMETRIAL CANCER AND ESTROGEN USE - REPORT OF A LARGE CASE-CONTROL STUDY
    ANTUNES, CMF
    STOLLEY, PD
    ROSENSHEIN, NB
    DAVIES, JL
    TONASCIA, JA
    BROWN, C
    BURNETT, L
    RUTLEDGE, A
    POKEMPNER, M
    GARCIA, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (01) : 9 - 13
  • [2] CLINICAL STAGE IB ENDOMETRIAL ADENOCARCINOMA WITH AN ISOLATED SMALL-BOWEL METASTASIS
    BOSSCHER, J
    BARNHILL, D
    OCONNOR, D
    PARK, R
    [J]. GYNECOLOGIC ONCOLOGY, 1994, 52 (01) : 99 - 101
  • [3] IMMUNOHISTOCHEMICAL EVALUATION OF ESTROGEN AND PROGESTERONE-RECEPTOR CONTENT IN 183 PATIENTS WITH ENDOMETRIAL CARCINOMA .1. CLINICAL AND HISTOLOGIC CORRELATIONS
    CARCANGIU, ML
    CHAMBERS, JT
    VOYNICK, IM
    PIRRO, M
    SCHWARTZ, PE
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 94 (03) : 247 - 254
  • [4] CHAPMAN GW, 1988, J NATL MED ASSOC, V80, P350
  • [5] CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO
  • [6] 2-8
  • [7] CREASMAN WT, 1986, OBSTET GYNECOL, V67, P326
  • [8] ESPINOS JJ, 1993, CUTIS, V52, P109
  • [9] FANNING J, 1987, OBSTET GYNECOL, V70, P920
  • [10] ESTROGEN REPLACEMENT THERAPY FOLLOWING TREATMENT FOR STAGE-I ENDOMETRIAL CARCINOMA
    LEE, RB
    BURKE, TW
    PARK, RC
    [J]. GYNECOLOGIC ONCOLOGY, 1990, 36 (02) : 189 - 191